Business Description
![Cannapharmarx Inc Cannapharmarx Inc logo](https://static.gurufocus.com/logos/0C00000D5K.png?14)
Cannapharmarx Inc
NAICS : 325412
SIC : 2834
ISIN : US13765D1090
Description
Cannapharmarx Inc is involved in the cannabis sector. The company negotiates, acquires, and develops various cannabis cultivation projects throughout Canada. Its three projects include the Hanover Project; the Great Northern Project, and the Acquisition of Sunniva Medical.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1.42 | |||||
Debt-to-Equity | -0.82 | |||||
Debt-to-EBITDA | 4.55 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -12.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 74.1 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | 44 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.12 | |||||
9-Day RSI | 57.95 | |||||
14-Day RSI | 53.1 | |||||
6-1 Month Momentum % | 10 | |||||
12-1 Month Momentum % | -21.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.01 | |||||
Days Inventory | 874 | |||||
Days Sales Outstanding | 1431.92 | |||||
Days Payable | 6506.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -111.1 | |||||
Shareholder Yield % | 11.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1680.77 | |||||
Operating Margin % | -4246.15 | |||||
Net Margin % | 2411.54 | |||||
FCF Margin % | -8319.23 | |||||
ROE % | Neg. Equity | |||||
ROA % | 6.92 | |||||
ROIC % | -5.2 | |||||
ROC (Joel Greenblatt) % | 50.43 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 6.75 | |||||
EV-to-EBITDA | 6.3 | |||||
EV-to-Revenue | 730.31 | |||||
EV-to-FCF | -9.74 | |||||
Earnings Yield (Greenblatt) % | 14.81 | |||||
FCF Yield % | -46.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CPMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cannapharmarx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.026 | ||
EPS (TTM) ($) | -0.002 | ||
Beta | -1859.56 | ||
Volatility % | 921.25 | ||
14-Day RSI | 53.1 | ||
14-Day ATR ($) | 0.001483 | ||
20-Day SMA ($) | 0.010228 | ||
12-1 Month Momentum % | -21.43 | ||
52-Week Range ($) | 0.0001 - 0.0279 | ||
Shares Outstanding (Mil) | 662.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cannapharmarx Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cannapharmarx Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cannapharmarx Inc Frequently Asked Questions
What is Cannapharmarx Inc(CPMD)'s stock price today?
The current price of CPMD is $0.01. The 52 week high of CPMD is $0.03 and 52 week low is $0.00.
When is next earnings date of Cannapharmarx Inc(CPMD)?
The next earnings date of Cannapharmarx Inc(CPMD) is 2024-11-15 Est..
Does Cannapharmarx Inc(CPMD) pay dividends? If so, how much?
Cannapharmarx Inc(CPMD) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |